Investing.com - Ocular Therapeutix Inc (NASDAQ: OCUL) reported first quarter EPS of $-0.49, $0.31 worse than the analyst estimate of $-0.18. Revenue for the quarter came in at $14.77M versus the consensus estimate of $15.36M.
Ocular Therapeutix Inc's stock price closed at $5.93. It is up 4.40% in the last 3 months and down -7.34% in the last 12 months.
Ocular Therapeutix Inc saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Ocular Therapeutix Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Ocular Therapeutix Inc's Financial Health score is "fair performance".
Check out Ocular Therapeutix Inc's recent earnings performance, and Ocular Therapeutix Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar